ClinConnect ClinConnect Logo
Search / Trial NCT04939922

China Headache and Vertigo Registry Study

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 17, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Migraine Headache Disorders Vertigo Vestibular Migraine Fibromyalgia

ClinConnect Summary

The China Headache Registry Study is looking at different types of headaches, including migraines, tension-type headaches, and other related conditions like vertigo and fibromyalgia. This study aims to gather information from patients aged 4 to 99 years to better understand the causes, symptoms, and treatments of these headache disorders. Researchers will examine various factors, such as genetics and heart function, and plan to follow participants over the long term to see how their conditions change.

To participate in this study, individuals must provide written consent and be diagnosed with specific headache types according to established guidelines. The study welcomes both males and females who fit within the age range. Participants will be asked to keep track of their headaches, but those unable to do so or who cannot commit to long-term follow-up will not be eligible. Overall, this research aims to improve our understanding of headache disorders and help develop better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
  • Male or female participants ages 4 to 99 years.
  • Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches.
  • Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).
  • Exclusion Criteria:
  • Patients who were unable to complete scales such as headache diary.
  • Patients denied or unable to be admitted for long-term follow-up.

About Second Affiliated Hospital, School Of Medicine, Zhejiang University

The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Hangzhou, Zhejiang, China

Patients applied

0 patients applied

Trial Officials

Kaiming Liu, Doctor

Principal Investigator

headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials